Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy
Hsin-I Chang1, Ming-Kung Yeh21Department of Biochemical Science and Technology, National Chia Yi University, Chiayi City, 2Institute of Preventive Medicine, National Defence Medical Center, Sanhsia, Taipei, TaiwanAbstract: Research on liposome formulations has progressed from that on conventional ve...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-12-01
|
Series: | International Journal of Nanomedicine |
Online Access: | http://www.dovepress.com/clinical-development-of-liposome-based-drugs-formulation-characterizat-a8980 |
id |
doaj-2011e8e45ba8406c8ba63568a056f627 |
---|---|
record_format |
Article |
spelling |
doaj-2011e8e45ba8406c8ba63568a056f6272020-11-24T23:53:36ZengDove Medical PressInternational Journal of Nanomedicine1176-91141178-20132011-12-012012default4960Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacyChang HIYeh MKHsin-I Chang1, Ming-Kung Yeh21Department of Biochemical Science and Technology, National Chia Yi University, Chiayi City, 2Institute of Preventive Medicine, National Defence Medical Center, Sanhsia, Taipei, TaiwanAbstract: Research on liposome formulations has progressed from that on conventional vesicles to new generation liposomes, such as cationic liposomes, temperature sensitive liposomes, and virosomes, by modulating the formulation techniques and lipid composition. Many research papers focus on the correlation of blood circulation time and drug accumulation in target tissues with physicochemical properties of liposomal formulations, including particle size, membrane lamellarity, surface charge, permeability, encapsulation volume, shelf time, and release rate. This review is mainly to compare the therapeutic effect of current clinically approved liposome-based drugs with free drugs, and to also determine the clinical effect via liposomal variations in lipid composition. Furthermore, the major preclinical and clinical data related to the principal liposomal formulations are also summarized.Keywords: PEGlated liposomes, temperature sensitive liposomes, therapeutic efficiency, virosomes, cationic liposomeshttp://www.dovepress.com/clinical-development-of-liposome-based-drugs-formulation-characterizat-a8980 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Chang HI Yeh MK |
spellingShingle |
Chang HI Yeh MK Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy International Journal of Nanomedicine |
author_facet |
Chang HI Yeh MK |
author_sort |
Chang HI |
title |
Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy |
title_short |
Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy |
title_full |
Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy |
title_fullStr |
Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy |
title_full_unstemmed |
Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy |
title_sort |
clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy |
publisher |
Dove Medical Press |
series |
International Journal of Nanomedicine |
issn |
1176-9114 1178-2013 |
publishDate |
2011-12-01 |
description |
Hsin-I Chang1, Ming-Kung Yeh21Department of Biochemical Science and Technology, National Chia Yi University, Chiayi City, 2Institute of Preventive Medicine, National Defence Medical Center, Sanhsia, Taipei, TaiwanAbstract: Research on liposome formulations has progressed from that on conventional vesicles to new generation liposomes, such as cationic liposomes, temperature sensitive liposomes, and virosomes, by modulating the formulation techniques and lipid composition. Many research papers focus on the correlation of blood circulation time and drug accumulation in target tissues with physicochemical properties of liposomal formulations, including particle size, membrane lamellarity, surface charge, permeability, encapsulation volume, shelf time, and release rate. This review is mainly to compare the therapeutic effect of current clinically approved liposome-based drugs with free drugs, and to also determine the clinical effect via liposomal variations in lipid composition. Furthermore, the major preclinical and clinical data related to the principal liposomal formulations are also summarized.Keywords: PEGlated liposomes, temperature sensitive liposomes, therapeutic efficiency, virosomes, cationic liposomes |
url |
http://www.dovepress.com/clinical-development-of-liposome-based-drugs-formulation-characterizat-a8980 |
work_keys_str_mv |
AT changhi clinicaldevelopmentofliposomebaseddrugsformulationcharacterizationandtherapeuticefficacy AT yehmk clinicaldevelopmentofliposomebaseddrugsformulationcharacterizationandtherapeuticefficacy |
_version_ |
1725468899439280128 |